The role of adipocytokines in colon cancer and adenomas

Journal of Medical Biochemistry

Volumn 33, Issue 2, 2014, Pages 135-142

  Tulubas, Feti ^a   Mete, Rafet ^a   Oznur, Meltem ^a   Topcu, Birol ^a  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Apelin; Colon adenoma; Colon cancer; Visfatin

Indexed keywords

EID: 84904330877     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/jomb-2015-0001     Document Type: Article

References (31)

1. Atamanalp SS, Şentürk F, Gürsan N, Öztürk G, Kantarci M, Yildirgan IM et al. Endoscopic polypectomy: outcomes of 467 cases in 20 years. Turk J Med Sci 2009; 39:747-53.
2. Erarslan E, Turkay C, Koktener A., Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adipo-nectin levels with colorectal neoplasia. Dig Dis Sci 2009; 54: 862-8.
3. Farquharson AJ, Steele RJ, Carey F.A., Drew JE Novel multiplex method to assess insulin, leptin and adipo-nectin regulation of inflammatory cytokines associated with colon cancer. Mol Biol Rep 2012; 39: 5727-36.
4. Tudek B, Speina E. Oxidatively damaged DNA and its repair in colon carcinogenesis. Mutat Res 2012; 736: 82-92.
5. Bećarević M, Seferović J, Ignjatović S, Singh S, Majkić-Singh N. Adiponectin non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitus. Journal of Medical Biochemistry 2012; 31:199-204.
6. Gulcelik MA, Colakoglu K, Dineer H., Dogan L, Yeni-dogan E, Gulcelik NE Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev 2012; 13: 395-8.
7. Canoruç N.E.K, Turhanoǧlu DA, Özmen Ş, Ogün C, Kaplan A. Plasma resistin and leptin levels in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 2009; 39: 447-51.
8. Gonullu G, Kahraman H, Bedir A., Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis 2010; 25: 205-12.
9. Heo K, Kim YH, Sung H.J., Li HY, Yoo CW, Kim JY, et al Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients. Oral Oncol 2012; 48: 500-6.
10. Dalamaga M, Archondakis S, Sotiropoulos G., Karma-niolas K, Pelekanos N, Papadavid E., et al. Could serum visfatin be a potential biomarker for postmenopausal breast cancer? Maturitas 2012; 71: 301-8.
11. Kelesidis I, Kelesidis T, Mantzoros CS Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94: 1221-5.
12. Moon HS, Uu X, Nagel J.M., Chamberiand JP, Diako-poulos KN, Brinkoetter MT, et al Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut 2012.
13. Fujisawa T, Endo H, Tomimoto A., Sugiyama M, Taka-hashi H, Saito S, et al Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008; 57: 1531-8.
14. Kim AY, Lee YS, Kim K.H., Lee JH, Lee HK, Jang SH, et al Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 2010; 24:1441-52.
15. Lukanova A, Soderberg S, Kaaks R., Jellum E, Stattin R Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 401-2. (Pubitemid 43342195)
16. Stocks T, Lukanova A, Johansson M., Rinaldi S, Palmqvist R, Hallmans G., et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008; 32: 304-14. (Pubitemid 351271779)
17. Kumor A, Daniel P, Pietruczuk M., Malecka-Panas E. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 2009; 24: 275-81.
18. Nakajima TE, Yamada Y, Hamano T., Furuta K, Matsuda T, Fujita S., et al. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010; 101:1286-91.
19. Nishihara T, Baba M, Matsuda M., Inoue M, Nishizawa Y, Fukuhara A., et al. Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol 2008; 14: 6473-80.
20. Stattin R Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-52. (Pubitemid 38160676)
21. Tessrtore L, Vizio B, Jenkins O., De Stefano I, Ritossa C, Argiles J.M., et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-6.
22. Salageanu A, Tucureanu C, Lerescu L., Caras I, Pitica R, Gangura G., et al. Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 2010; 3: 416-20.
23. Wagsater D, Mumtaz M, Lofgren S., Hugander A, Dim-berg J. Resistin in human colorectal cancer: increased expression independently of resistin promoter-420C > G genotype. Cancer Invest 2008; 26: 1008-14.
24. Sun CA, Wu MH, Chu C.H., Chou YC, Hsu GC, Yang T, et al Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat 2010; 123: 869-76.
25. Sorti SC, Le Gonidec S, Knibiehler B, Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007; 26: 7692-9. (Pubitemid 350224216)
26. Berta J, Kenessey I, Dobos J., Tovari J, Klepetko W, Jan Ankersmit H, et al. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. J Thorac Oncol 2010; 5: 1120-9.
27. Kasai A, Shintani N, Kato H., Matsuda S, Gomi F, Haba R., et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 1717-22.
28. Carpene C, Dray C, Attane C., Valet R Portillo MR Churruca I, et al. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63:359-73.
29. Yener S, Comlekci A, Yuksel R Sevinc A, Ertilav S, Yesil S. Traditional and novel cardiovascular risk factors in nonfunctioning adrenal adenomas. Eur J Intern Med 2012; 23: 83-7.
30. Tilg H, Moschen AR Role of adiponectin and PBEF/vis-fatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 2008; 114: 275-88. (Pubitemid 351294003)
31. Kim JG, Kim EO, Jeong B.R., Min YJ, Park JW, Kim ES, et al Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells 2010; 30: 341-5.